ConvaTec stock sits 28.82 percent below GBp 305.44 target
Published on 10/15/2026 at 20:40 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSTarget and valuation points
- MarketBeat listed a GBp 305.44 average target and nine analyst ratings on October 14, 2026.
- ConvaTec reported 5.00 percent organic revenue growth and a 21.20 percent operating margin in the first half of 2026.
- ConvaTec stock costs EUR 2.82 at Lang & Schwarz on October 15, 2026 at 8:34 p.m. CEST, up 0.94 percent on the day on the LSE.
- ConvaTec's next earnings report is scheduled for February 23, 2027, while its P/E ratio is 50.38.
MarketBeat listed a GBp 305.44 average target for ConvaTec and nine analyst ratings on October 14, 2026. The target is 28.82 percent above the LSE price of GBp 236.80 on October 15, 2026. ConvaTec stock was trading at EUR 2.82 at Lang & Schwarz on October 15, 2026 at 8:34 p.m. CEST, while the LSE quote was up 0.94 percent on the day.
First-half growth supports the view
ConvaTec reported 5.00 percent organic revenue growth excluding InnovaMatrix in the first half of 2026, with an operating margin of 21.20 percent. Investing.com also reported that the company reaffirmed full-year 2026 guidance for an operating margin of at least 23.00 percent and double-digit earnings-per-share growth.
Stock stays below its yearly high
The LSE price stood at GBp 236.80 on October 15, 2026, within a 52-week range of GBp 193.00 to GBp 259.30. That places the stock 8.68 percent below its yearly high. Trading volume was 24,281,063 shares against an average of 7,986,309 shares.
The market capitalization was GBP 4.5 billion on October 15, 2026, and the P/E ratio was 50.38. The current valuation therefore sits above Smith & Nephew's 19.52 ratio and Coloplast's 38.21 ratio, based on the same day's quoted figures.
When is the next reporting date?
Investing.com lists February 23, 2027 as ConvaTec's next earnings date. That calendar point gives the valuation a clear next checkpoint, while the first-half margin and the 23.00 percent full-year threshold define the operating measures investors will compare.
Comparison with peers
ConvaTec (LSE, GBp): up 0.94 percent, P/E 50.38, market capitalization GBP 4.5 billion
Smith & Nephew (LSE, GBp): up 3.62 percent, P/E 19.52, market capitalization GBP 9.1 billion
Coloplast (Nasdaq Copenhagen, DKK): up 2.90 percent, P/E 38.21, market capitalization DKK 105.6 billion
Price and investor perspective
ConvaTec was trading at EUR 2.82 at Lang & Schwarz on October 15, 2026 at 8:34 p.m. CEST. The LSE price was up 0.94 percent on October 15, 2026, while the 52-week high remained GBp 259.30.
The further course of trading is shown by the continuously updated real-time quote of ConvaTec stock.
ConvaTec stock market facts
- Company: ConvaTec Group Plc
- ISIN: GB00BD3VFW73
- Ticker: CTEC
- Primary exchange: London Stock Exchange
- Price Lang & Schwarz (as of October 15, 2026, 8:34 p.m. CEST): EUR 2.82
- Change on the LSE: plus 0.94 percent
- Market capitalization: GBP 4.5 billion (as of October 15, 2026)
- 52-week range: GBp 193.00-259.30 (as of October 15, 2026)
- Sector / Industry: Healthcare / Healthcare Equipment and Supplies
- Next earnings date: February 23, 2027
Market context: Market report FTSE 100.
